GW
IMGN

GW & Wade’s Immunogen Inc IMGN Stock Holding History

GW & Wade’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,906
Closed -$105K – 396
2021
Q2 		$105K Buy
+15,906
New +$111K 0.01% 379
2017
Q2 		– Sell
-18,264
Closed -$71K – 244
2017
Q1 		$71K Hold
18,264
– – 0.01% 239
2016
Q4 		$37K Sell
18,264
-15,000
-45% -$30.1K 0.01% 224
2016
Q3 		$89K Hold
33,264
– – 0.02% 225
2016
Q2 		$102K Buy
+33,264
New +$209K 0.02% 228

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GW & Wade's IMGN Position: Q3 2021 in Review

GW & Wade sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 15,906 shares — an estimated $105K sold.

GW & Wade first reported a position in IMGN in Q2 2016 and held it in 5 quarters. The position peaked at $105K in Q2 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

  • GW & Wade reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
  • GW & Wade sold 15,906 Immunogen Inc shares in Q3 2021, an estimated $105K.
  • GW & Wade first reported a position in Immunogen Inc in Q2 2016 and held it in 5 quarters.
  • GW & Wade's Immunogen Inc position peaked at $105K in Q2 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on GW & Wade's 13F filing for Q3 2021, filed 3 Nov 2021.